What question did this study set out to answer?

To examine prescribing patterns and utilization of antiobesity medications using electronic health record data among eligible individuals.

October 11, 2019ObesityOpen Access

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015

View Full Paper

Ask AI

Bookmark

Authors

DSDavid SaxonNorthwestern University SISean J. IwamotoUniversity of Colorado Anschutz Medical Campus CMChristie MettenbrinkDenver Health Medical Center

Discussion

Member takes

Implication

Cohort study reveals low overall antiobesity medication prescribing in eligible adults, indicating concentrated prescribing practices and heavy reliance on phentermine.

Key Points

To examine prescribing patterns and utilization of antiobesity medications using electronic health record data among eligible individuals.
Retrospective cohort study utilizing pharmacy- and patient-level electronic health record data from eight geographically dispersed health care organizations between 2009 and 2015.
Analyzed data from 2,248,407 adults eligible for weight-loss medications.
Phentermine accounted for 76.6% of all prescriptions, with 51.7% filled for ≥ 120 days and 33.8% filled for ≥ 360 days.
Overall medication days rose by 32.9% from 2009 to 2015, with higher prescription rates observed in women, Black individuals, and patients in higher body mass index classes.
Of 3,919 providers who wrote at least one filled prescription, 23.8% (n = 863) were frequent prescribers who wrote 89.6% of all filled prescriptions.

Cite This Study

Saxon et al. (2019) studied this question.

synapsesocial.com/papers/69fd378437bfdcfbd7509ed6 https://doi.org/10.1002/oby.22581

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals low overall antiobesity medication prescribing in eligible adults, indicating concentrated prescribing practices and heavy reliance on phentermine.

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015

Discussion

Member takes

Implication

Key Points

Cite This Study

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider